Search

Sanofi SA

Closed

SectorHealthcare

76.82 -0.66

Overview

Share price change

24h

Current

Min

77.16

Max

77.54

Key metrics

By Trading Economics

Income

317M

1.9B

Sales

1.1B

12B

P/E

Sector Avg

24.161

57.366

EPS

2.09

Dividend yield

5.22

Profit margin

15.699

Employees

74,846

EBITDA

-1B

1.7B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+20.42% upside

Dividends

By Acuity

Dividend yield

Sector Avg

5.22%

2.16%

Next Earnings

30 paź 2026

Market Stats

By TradingEconomics

Market Cap

679M

94B

Previous open

77.48

Previous close

76.82

News Sentiment

By Acuity

69%

31%

299 / 340 Ranking in Healthcare

Sanofi SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

29 sie 2026, 00:02 UTC

News
Correlated Moves

Delta Air Lines shares are higher in after-market trading following the court's approval of its joint venture with Grupo Aeroméxico and record Q2 revenue of $17.7 billion.

29 sie 2026, 00:02 UTC

News

Pinterest Inc shares declined in after-market trading following CFO Julia Brau Donnelly's resignation, effective October 30. Vikram Naidu will serve as interim CFO.

29 sie 2026, 00:02 UTC

News

Chevron is nearing multi-billion-dollar deals to expand operations in Venezuela, boosting shares in after-market trading amid rising global crude prices.

29 sie 2026, 00:01 UTC

News

Johnson & Johnson shares higher in after-market trading following FDA approval of Stelara for pediatric ulcerative colitis treatment, expanding its market potential.

29 sie 2026, 00:01 UTC

News

Planet Fitness shares are lower in after-market hours following a class action lawsuit alleging misleading statements about customer metrics and growth guidance.

29 sie 2026, 00:01 UTC

News

Blue Owl Capital Inc. shares rose in after-market trading following its $2.4 billion debt deal for Iren Ltd. to acquire Nvidia Blackwell Ultra GPUs.

29 sie 2026, 00:01 UTC

News

Vistra Corp reports gross revenue of $17.74 billion and net income of $944 million. Shares are higher in after-market hours, reflecting strong institutional confidence.

29 sie 2026, 00:01 UTC

News

Group 1 Automotive shares declined in after-market hours following multiple broker downgrades and price target reductions, including Barclays lowering its target to $365.

28 sie 2026, 23:56 UTC

News

nVent Electric PLC will acquire Maverick Power for $1.75 billion, with additional performance-based payments. Shares are higher during after-market hours following the announcement.

28 sie 2026, 23:46 UTC

News

Diamondback Energy shares declined after-market, despite earlier gains, amid rising market expectations for a rate hike and increased Treasury yields.

28 sie 2026, 23:46 UTC

News

Target Corp filed for a mixed securities shelf and registered 15.5 million shares under its employee incentive plan. Shares remained roughly flat in after-market hours.

28 sie 2026, 23:41 UTC

News

Blue Owl Capital gained in after-market trading after leading a $2.4 billion financing deal for Iren Ltd. to purchase Nvidia Blackwell Ultra GPUs.

28 sie 2026, 23:41 UTC

News

Group 1 Automotive Inc shares declined in after-market hours, pressured by ratings downgrades from Barclays PLC and Weiss Ratings amid rising Treasury yields.

28 sie 2026, 23:21 UTC

News

Incyte Corp shares are lower in after-market trading, continuing a trend of four consecutive sessions finishing down amid rising Treasury yields and mixed ESMO data sentiment.

28 sie 2026, 23:21 UTC

News

Intuit Inc. shares are trading lower in after-market hours following a class action lawsuit alleging misleading statements about its financial performance and competitive advantages.

28 sie 2026, 23:06 UTC

News

Coherus Oncology's $50 million common share offering pressures shares lower in after-market trading, marking a pullback from recent highs.

28 sie 2026, 23:06 UTC

News

BioNTech SE shares are higher in after-market trading, supported by a Strong Buy rating and a cash position of $19.28 billion for R&D efforts.

28 sie 2026, 23:06 UTC

Macro Event
News

Bitcoin is trading lower as hawkish comments from Federal Reserve Chairman Kevin Warsh raise interest rate expectations and geopolitical tensions impact investor confidence.

28 sie 2026, 23:06 UTC

Macro Event
News

Bitcoin is trading lower as hawkish comments from Federal Reserve Chairman Kevin Warsh raise interest rate hike expectations and geopolitical tensions impact market confidence.

28 sie 2026, 23:06 UTC

News

Lowe's Companies declared a quarterly cash dividend of $1.25 per share, boosting shares in after-market trading following the announcement.

28 sie 2026, 23:06 UTC

News

Visa Inc shares are higher in after-market trading following a partnership with Dunamu to develop stablecoin payments and cross-border remittance services.

28 sie 2026, 23:06 UTC

News

Michael Burry has reduced his stake in PayPal as acquisition talks with Advent International and Stripe have ended. Shares are slightly higher in after-hours trading.

28 sie 2026, 23:02 UTC

News

Halliburton Co is positioned for multi-billion-dollar deals in Venezuelan crude reserves, contributing to higher shares in after-market hours.

28 sie 2026, 23:01 UTC

News

Pinterest Inc shares declined in after-market trading following the resignation announcement of CFO Julia Brau Donnelly, effective October 30, 2026. Trading remains weak overall.

28 sie 2026, 23:01 UTC

News

Chemours Co faces an investigation by Pomerantz LLP over potential securities law violations. Shares are trading higher in after-market hours despite concerns over internal controls.

28 sie 2026, 23:01 UTC

News

Alnylam Pharmaceuticals shares rose in after-market hours, despite concerns from a failed cardiomyopathy trial. The company's market capitalization stands at $31.57 billion.

28 sie 2026, 23:01 UTC

News

Flowers Foods shares are lower in after-market trading following the filing of a mixed securities shelf, raising potential concerns about dilution and financial strategy.

28 sie 2026, 23:01 UTC

Event
News

Eli Lilly's shares rise in after-market trading following FDA approval of Mounjaro for reducing cardiovascular risks in type 2 diabetes patients.

28 sie 2026, 23:01 UTC

News

Chevron is nearing multi-billion-dollar deals to expand operations in Venezuela, targeting two heavy-oil fields. Shares are trading higher in after-market hours.

28 sie 2026, 23:01 UTC

News

McKesson Corp disclosed a cybersecurity incident affecting its information systems, with shares trading lower in after-market hours amid broader market weakness.

Peer Comparison

Price change

Sanofi SA Forecast

Price Target

By TipRanks

20.42% upside

12 Months Forecast

Average 93.025 EUR  20.42%

High 106.21 EUR

Low 78 EUR

Based on 10 Wall Street analysts offering 12 month price targets forSanofi SA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

5

Buy

5

Hold

0

Sell

Sentiment

By Acuity

299 / 340 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Sanofi SA

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
help-icon Live chat